Paragonix Technologies Inc. Closes $1.1 Million Convertible Debt Financing

BRAINTREE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc., a medical device company based in Braintree, MA, developing the Sherpa™ product line for organ preservation and transportation, today announced that the Company’s $1.1M convertible debt round has been successfully closed. “This financing enables the company to execute on our strategic and development plans under a capital efficient business model,” noted Bill Edelman, Paragonix’s Chairman and CEO. “We look back on 2013 as a highly productive year, with one 510(k) FDA Pre-market Notification clearance received in February and two additional 510(k) FDA submissions filed, expanding the Sherpa product line.”

Help employers find you! Check out all the jobs and post your resume.